GGrantIndex
Sort

48,018 grants matching immunotherapy

Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis

$578,640
Efstathios Karathanasis · Case Western Reserve University · R01 · FY2022 · CA

Administrative Core

$578,637
Rosalie Wollett · Johns Hopkins University · P30 · FY2023 · CA

Administrative Core

$578,637
Rosalie Wollett · Johns Hopkins University · P30 · FY2022 · CA

Administrative Core

$578,637
Rosalie Wollett · Johns Hopkins University · P30 · FY2024 · CA

Program Leaders

$578,599
Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2015 · CA

Biologic Activity of Transferred HIV-specific CD8 Clones

$578,592
Fred Hutchinson Cancer Research Center · U01 · FY2003 · AI

Program Leaders

$578,576
Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2015 · CA

Project 2: Radiation-Induced Lymphopenia: Understanding, Predictive Modeling and Developing Photon and Proton-Based Mitigation Strategies.

$578,510
Steven Hsesheng Lin · Massachusetts General Hospital · P01 · FY2023 · CA

Single Cell Methods for Bioeffector Discovery and Analysis

$578,443
Brian O Bachmann · Vanderbilt University · R01 · FY2021 · CA

Towards Translation of MU-CN29: New Therapeutic Nanoparticle for Drug-Resistant NSCLC

$578,421
Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2023 · CA

ChAT, AChE, and Cholinergic Neurons in Aging and AD

$578,370
Steven G Younkin · Mayo Clinic Jacksonville · R01 · FY2011 · AG

Diversification of Cytotoxic Effector Cells Via LPS-activated DCs

$578,305
Anna Karolina Palucka · Baylor Research Institute · R01 · FY2010 · CA

New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer

$578,297
James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2022 · DE

(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis

$578,253
Enrique A Mesri · University Of Miami School Of Medicine · R01 · FY2021 · CA

Identifying the mechanism of anti-colorectal immunity induced by mucoinvasive colonic bacteria

$578,243
Timothy Wesley Hand · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA

Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment

$578,201
Jun Wang · New York University School Of Medicine · R01 · FY2025 · CA

Training Grant in Molecular Imaging Research

$578,185
Ralph Weissleder · Massachusetts General Hospital · T32 · FY2020 · CA

Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to AD

$578,141
Jonathan Kipnis · Washington University · R01 · FY2024 · AG

Heterogeneity of T cell phenotype and function in food allergy

$578,135
Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AI

Chromatin and transcriptional regulatory factors that initiate and stabilize memory CD8 T cell development

$578,092
Matthew Eugene Pipkin · University Of Florida · P01 · FY2024 · AI

Targeted immuno-nanoparticles for directing antitumor immune response against breast cancer metastasis

$578,041
Efstathios Karathanasis · Case Western Reserve University · R01 · FY2023 · CA

Immunotherapeutic responses to neoantigens in head and neck cancer

$578,036
Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2021 · DE

Immunotherapeutic responses to neoantigens in head and neck cancer

$578,036
Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2020 · DE

Immunotherapeutic responses to neoantigens in head and neck cancer

$578,036
Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2018 · DE

Immunotherapeutic responses to neoantigens in head and neck cancer

$578,036
Ravindra Uppaluri · Dana-Farber Cancer Inst · R01 · FY2019 · DE